di Reumatologia, Società Italiana, trans. 2025. “PO:08:113 | Shaping Rheumatoid Arthritis Treatment: Clinical and Demographic Drivers of TsDMARDs Versus BDMARDs Prescription Post-EMA Pronouncement on JAK Inhibitors - Insights from the AMBI-RA Study: Riccardo Bertola1, Beatrice Maranini1, Carlo Garaffoni1, Maria Pozzuto1, Anna Laura Riva Cambrino1, Alessandro Spinelli1, Letizia Mamprin1, Federico Agostini1, Martina Di Nunzio1, Marcello Govoni1, Alessandra Bortoluzzi1, Ettore Silvagni1 | 1Rheumatology Unit, Department of Medical Sciences, University of Ferrara and Azienda Ospedaliero-Universitaria S. Anna, Italy”. Reumatismo 77 (s1). https://doi.org/10.4081/reumatismo.2025.2139.